When it comes to treatment, our health care system should place need and potential benefit above profit.
U.S. patients spend more than $200 billion each year on procedures and treatments that are considered “low value,” or unnecessary, often because providers have a financial incentive to recommend them. And because low-value care involves treatment that is not supported by clinical research, the potential harm to patients can outweigh the possible benefits.
We are focused on identifying and avoiding drivers of low-value care to reduce wasteful spending, eliminate harm to patients, and increase efficiency in the health care system. We support interventions and payment reforms that give providers financial incentives to deliver coordinated, high-quality care to patients. We work with researchers and clinicians to identify and develop approaches that ensure patients receive appropriate services.